Compounds > 4-amino-5-chloro-N-[(3R-4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide

4-amino-5-chloro-N-[(3R-4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide and Liver-Neoplasms

4-amino-5-chloro-N-[(3R-4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide has been researched along with Liver-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 4-amino-5-chloro-N-[(3R-4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide and Liver-Neoplasms

ArticleYear
Discovery of 1,6-Naphthyridin-2(1
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Fibroblast growth factor receptor 4 (FGFR4) has been identified as a potential target due to its transmission of the FGF19 signaling pathway, which is critical to hepatocellular carcinoma (HCC). Therefore, focusing on the specific Cys552 of FGFR4 subtype, we designed and synthesized a novel family of 1,6-naphthyridin-2(1

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Fibroblast Growth Factors; Humans; Liver Neoplasms; Naphthyridines; Receptor, Fibroblast Growth Factor, Type 4

2022